Letter/Communication
Betibeglogene Autotemcel Gene Therapy for Transfusion-Dependent β-Thalassemia
NEJM journal watch. Oncology & hematology
11/27/2024
Abstract
Beti-cel showed promising results in achieving transfusion independence for the majority of patients with severe genotypes.
Details
- Title: Subtitle
- Betibeglogene Autotemcel Gene Therapy for Transfusion-Dependent β-Thalassemia
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 11/27/2024
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984752660302771
Metrics
8 Record Views